Skip to main content

MARSHALL WACE, LLP

Position in MGNX — Macrogenics Inc

CIK 1318757 LONDON, X0

Position in MGNX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,466,936
+$1,613,167 QoQ
Shares Held
1,616,220
-20.2% QoQ
Ownership
2.54%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 122 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. MGNX ranks #81 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MGNX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,466,936 1,616,220
2026-03-31 $5,853,769 2,025,526
2025-12-31 $2,068,145 1,284,563
2025-09-30 $1,057,618 629,535
2025-06-30 $491,151 405,911
2025-03-31 $379,764 299,028
2024-12-31 $1,279,739 393,766
2024-09-30 $1,255,186 381,516
2024-06-30 $2,796,529 658,007
2024-03-31 $541,328 36,775
2023-06-30 $459,185 85,829
2023-03-31 $1,849,487 257,948
2022-09-30 $824,514 238,299
2022-06-30 $2,050,084 694,944
2021-09-30 $419,867 20,051
2020-12-31 $871,491 38,123
2020-03-31 $369,430 63,476